Back

Invasive quantitative assessment of coronary microvascular dysfunction in patients with hypertrophic cardiomyopathy

1 September 2024 (14:00 - 14:50)
Organised by: Logo
Congress Presentation Part of: Hypertrophic cardiomyopathy: risk prediction and outcomes Hypertrophic Cardiomyopathy ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Miguel Marques Antunes

Centro Hospitalar Universitario de Lisboa Central, E.P.E., Lisboa (Portugal)

6 More presentations in this session

Presentation thumbnail
CMR phenotypes and clinical outcomes in NYHA class I versus II-IV hypertrophic cardiomyopathy: identifying high-risk asymptomatic patients
Doctor D. Labib (Calgary, CA)
Abstract Slides Video
Presentation thumbnail
High-intensity exercise-related sudden cardiac death in hypertrophy cardiomyopathy
Doctor H. Lee (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
One-year outcomes of patients with hypertrophic cardiomyopathy according to levels of inflammatory biomarkers
Doctor M. Golino (Jacksonville, US)
Abstract Slides Video
Presentation thumbnail
The relationship between serum lumican levels and myocardial fibrosis in patients with hypertrophic cardiomyopathy
Doctor E. Hancioglu (Hatay, TR)
Abstract Slides Video
Presentation thumbnail
Prolonged ventricular activation time as a novel biomarker identifying burn-out phase of hypertrophic cardiomyopathy
Doctor K. Fragkiadakis (Heraklion, GR)
Abstract Slides Video

Access the full session

Session thumbnail
Hypertrophic cardiomyopathy: risk prediction and outcomes

The Event

Event poster

ESC Congress 2024

1 September 2024 14:00 CET
You may be interested in
thumbnail
Congress Presentation
Outcomes of microvascular dysfunction in patients with chronic coronary syndromes
thumbnail
Congress Session
Comprehensive diagnosis and treatment of coronary microvascular dysfunction in patients with chronic coronary syndromes
thumbnail
Congress Presentation
Longitudinal assessment of coronary microvascular dysfunction in an all-comer patient population detects the highly dynamic natural history of this condition

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources